Ask any systematic trader why their backtested mean-reversion strategy looks brilliant on paper but bleeds in live trading, and nine times out of ten, short-selling constraints are somewhere in the confession. This question matters enormously because the ASX is not a frictionless academic playground — it's a market with specific rules, stock availability lists, and borrow costs that punch you in the face the moment you try to short the overextended side of a reversion trade.
The direct answer is this: short-selling constraints on the ASX create an asymmetry where the long leg of a mean-reversion strategy executes cleanly, but the short leg faces availability friction, higher costs, and regulatory boundaries that erode returns in ways your backtest almost certainly never modelled. That gap between simulated and live performance is not bad luck — it's structural.
ASIC maintains an approved short sale product list covering eligible ASX securities. A significant portion of the ASX by stock count — particularly smaller and micro-cap names — sits outside that list entirely. Mean-reversion strategies, by their nature, often fish in exactly these less-liquid, smaller-capitalisation waters where prices overshoot most dramatically. The irony is almost poetic: the stocks that revert hardest are frequently the ones you can't legally short.
Think of it like running a pizza arbitrage business where you can freely buy cheap pizzas anywhere, but you're only allowed to sell — or "short" — approved pizzas from a government list. Your strategy might look incredible in theory, but half your trades disappear the moment reality shows up. Borrow costs compound this further: when a stock is available to short but heavily sought after, the stock lending fee can consume the entire theoretical edge of the trade, leaving you with a beautifully executed zero-return position.
Systematic traders navigating this terrain generally pursue one of several adaptations. Some run long-biased mean-reversion models that exploit only the bounce leg, accepting lower theoretical returns for drastically simpler execution. Others screen their universe upfront to include only ASX-approved shortable securities with liquid borrow, effectively pre-filtering the strategy before a signal is ever generated. Research on short-sale constraints and their price impact — well documented across academic literature and accessible through resources like Investopedia's short selling explainer, the broader theory behind short finance on Wikipedia, and technical breakdowns of mean reversion as a trading concept — consistently shows that constrained markets lead to overpriced securities and muted reversion speed on the short side.
The practical takeaway is blunt: before you run any mean-reversion system on the ASX, pull ASIC's approved short sale list, cross-reference your intended universe, and model realistic borrow costs into your expected edge. Do that first, and you'll know immediately whether your strategy is a business or a fantasy.
A backtest that ignores short-selling constraints isn't a strategy — it's a wish list with chart lines.
This content is for educational purposes only and does not constitute financial product advice. Past performance is not indicative of future results. Profit Logic Ltd (ACN 688 669 936) accepts no responsibility for errors or omissions in this content or anywhere on this website. Always seek advice from a licensed financial adviser before making investment decisions.